Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05921682

Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke

The goal of this observational study is to explore the optimal target body temperature in first 24 hours and the relationship between body temperature and adverse outcomes of heat stroke.

The main questions it aims to answer are:

* the optimal target body temperature at 0.5 h, 2 h, and the lowest body temperature of heat stroke. * the best body temperature at the cutting point of stop cooling. * The relationship between the volume and speed of ice saline infusion and the cooling effect.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heat Stroke Heat Stress Disorders Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Yiwu Central Hospital, Yiwu, Zhejiang, China

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 18 years; ② diagnosed as heat stroke; ③ Informed consent from patients or family members.

Exclusion criteria

  • need immediate cardiopulmonary resuscitation; ② transferred from another hospital; ③ with severe underlying organ insufficiency; ④ pregnant women.

Treatment and study plan

observation

Other

This study is an observational study. Patients will receive conventional cooling measures and organ function support.

Primary outcomes

  1. mortality

    Time frame: up to 90 days

    Number of participants who dead during hospitalization

  2. organ damage

    Time frame: up to 90 days

    Number of participants with organ damage, including but not limited to brain, lung, heart, kidney, liver and coagulation

Secondary outcomes

  1. continuous renal replacement therapy

    Time frame: up to 90 days

    Number of participants who need CRRT

  2. length of ICU stay

    Time frame: up to 90 days

    The length patient stay in ICU

  3. length of hospital stay

    Time frame: up to 90 days

    The length patient stay in hospital

Study contacts

Contact information is provided by the study sponsor or research team.

Lan Chen

CONTACT

[email protected]

+8613819987120

Xiuqin Feng

CONTACT

[email protected]

+8613757119151

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Collaborators

  • Dongyang People's Hospital
  • Jinhua Municipal Central Hospital
  • Jinhua People's Hospital
  • Lanxi People's Hospital
  • Yiwu Central Hospital

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Jun 27, 2023
Registry last updated
Sep 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.